Cancer patients backing orphan drug research
For cancer patients, it is a sad, but true fact, that drug companies will not back research into possible andpromising new drugs to fight cancer if the potential for profit is not part of the equation. CLL Topics Inc. of Arizonaand CLL Global Research Foundation of Texas, both non-profit organizations, are privately funding National Cancer Institute sponsored research in Mayo Clinic’shuman trials of an extract found in green tea, epigallocatechin gallate, to determine if the extract has any promise inthe treatment for leukemia. The founders of both organizations sufInexpensive drugs, over the counter drugs or drugs that cannot be patented, such as EGCG from green tea, are drugsthat
